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Adhesive Small Bowel Obstruction 
in the Minimally Invasive Era
Pepijn Krielen, Martijn W. J. Stommel,  
Richard P. G. ten Broek and Harry van Goor
Abstract
Roughly 60% of all cases of small bowel obstruction are caused by adhesions. 
Adhesions are a form of internal scar tissue, which develop in over 45–93% of 
patients who undergo abdominal surgery. With this relatively high incidence, 
the population at risk for adhesive small bowel obstruction (ASBO) is enormous. 
Minimally invasive surgery reduces surgical wound surface and thus holds 
promise to reduce adhesion formation. The use of minimally invasive techniques 
results in a 50% reduction of adhesion formation as compared to open surgery. 
However, since ASBO can be caused by just a single adhesive band, it is uncer-
tain whether a reduction in adhesion formation will also lead to a proportional 
decrease in the incidence of ASBO. Minimally invasive surgery might also 
improve operative treatment of ASBO, accelerating gastro-intestinal recovery 
time and lowering the risk of recurrent ASBO associated with adhesion reforma-
tion. We will discuss recent evidence on the impact of minimally invasive surgery 
on the incidence of ASBO and the role of minimally invasive surgery to resolve 
ASBO. Finally, we will debate additional measures, such as the use of adhesion 
barriers, to prevent adhesion formation and adhesion-related morbidity in the 
minimally invasive era.
Keywords: adhesions, adhesive small bowel obstruction, minimally invasive surgery, 
laparoscopy, adhesion barrier, adhesion reduction strategies
1. Introduction
As many as 60% of all episodes of small bowel obstruction (SBO) are caused by 
adhesions [1]. Adhesions are attachments of abdominal structures by internal scar 
tissue that are the result of healing of the peritoneum after it has been damaged, 
in most cases by surgery [2]. Adhesions can be filmy or dense and be present as an 
isolated band or as a ‘curtain’ or tangle with difficulty recognizing visceral struc-
tures. The degree of density and vascularization is traditionally classified using the 
Zühlke classification (Table 1) [3]. A more comprehensive and clinically relevant 
classification including projected locations of adhesions is the Peritoneal Adhesion 
Index (PAI) (Figure 1) [4, 5].
Adhesions develop in 89–93% of patients undergoing open abdominal or 
pelvic surgery [6, 7]. Incidence rates of adhesion formation are lower after mini-
mally invasive surgery, 45–62% [7, 8]. Adhesions can also develop after other 
causes of peritoneal trauma, such as inflammatory conditions or radiotherapy [2]. 
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Figure 1. 
Peritoneal adhesion index.
Grade Description
0 No adhesions or insignificant adhesions
I Adhesions that are filmy and easy to separate by blunt dissection
II Adhesions with beginning vascularization that can be dissected blunt but some sharp 
dissection is necessary
III Adhesions with clear vascularization that can only be dissected using sharp dissection
IV Adhesions which strongly attached organs, dissection is only possible by sharp 
dissection, damage of organs is hardly preventable
Adapted from Ref. [3].
Table 1. 
Zühlke classification.
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The occurrence of adhesions does not only cause a lifelong risk of adhesive small 
bowel obstruction (ASBO). Other clinical consequences of adhesions are dif-
ficulties during reoperation, female infertility, and chronic visceral pain; making 
it the most common cause of long-term complications in peritoneal surgery [1]. 
The incidence of ASBO is 2–3% in the first years after surgery in all patients 
who undergo abdominal or pelvic surgery [1]. The risk of ASBO depends on the 
anatomical location of surgery and the extent of surgery and peritoneal injury 
[1–10]. ASBO risk varies from 0.5% in abdominal wall surgery, 1.2% after upper 
gastrointestinal tract surgery to 3.2% in lower gastro-intestinal tract surgery and 
4.2% in pediatric surgery [1].
Given the high incidence of adhesions and adhesion-related complications, 
one would assume that every surgeon is aware of the risks of adhesions. However, 
awareness on the full size of the problem only arose in response to the publication 
of the Surgical and Clinical Adhesion Research (SCAR) study two decades ago. The 
SCAR large population based study demonstrated that one of three patients under-
going abdominal surgery is readmitted for a cause possibly related to adhesions [11]. 
Subsequently adhesion-related complications gained increasing awareness of clini-
cians, hospitals and vendors, and adhesion reduction strategies were introduced. 
Laparoscopic surgeons hypothesized that minimally invasive surgical techniques 
would reduce peritoneal injury and thereby could solve the problem of adhesion 
formation. Other strategies to reduce adhesion formation were the development of 
adhesion barriers, the banishment of powdered gloves, and the introduction of new 
sealing devices [12].
Over the past decades, minimally invasive surgery has become the standard 
approach in many surgical disciplines. The rapid introduction of minimally invasive 
surgery was largely fueled by short-term benefits such as quicker recovery, reduced 
pain, and better cosmetic outcome [13]. Furthermore, surgeons strongly believed in 
the effectiveness of minimally invasive surgical techniques to reduce adhesion for-
mation and subsequent morbidity [14]. For this reasons adhesion barriers are only 
seldomly used in minimally invasive surgery [15], and are believed to be needed 
only in open surgery. Despite good evidence of effective reduction of adhesion 
formation and subsequent adhesion-related morbidity, the use of adhesion barriers 
in open surgery is also limited [16]. Reasons for not using adhesion barriers are the 
lack of trust in adhesion reduction, the expected limited impact on adhesion-related 
complications, and the costs of the barriers [15]. The limited use of adhesion barri-
ers has slowed down the research and development of adhesion-prevention strate-
gies in the past decade.
Studies on adhesion formation in minimally invasive surgery report a reduction 
of approximately 50% in the extent of postoperative adhesions compared with 
open surgery [7]. Unfortunately, trials comparing open and minimally invasive 
surgery have not been designed and powered to compare long-term adhesion-
related outcomes [17]. Therefore, the effect of the broad implementation of mini-
mally invasive surgery on clinically relevant outcome parameters such as ASBO 
and readmissions is unknown [17]. A reduction in adhesion formation, does not 
necessarily correlate with a proportionate reduction in the risk of ASBO; a single 
adhesive band may cause a life-threatening bowel obstruction, whereas extensive 
dense abdominal adhesions may be asymptomatic [18]. Nevertheless, potential 
benefits of minimally invasive surgery in preventing adhesion-related morbidity 
seem compelling.
Minimally invasive surgery may also play a role in the treatment of 
ASBO. Approximately 25% of patients with ASBO require surgery to resolve the 
bowel obstruction [1], and recurrence rates are high [19]. The minimally invasive 
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approach is hypothesized to accelerate recovery, and might also reduce risk of 
regrowth of adhesions and subsequent recurrence of ASBO. A caveat is the small 
working space and vulnerability of the bowel caused by the distention of the 
obstructed bowel that could result in iatrogenic injuries. In this chapter, we discuss 
recent evidence on the effects of the introduction of minimally invasive surgery 
on the burden of adhesions and ASBO. We further discuss the role of minimally 
invasive surgery in the treatment of patients with ASBO. We end with a contempla-
tion on the awareness of adhesion-related complications and the value of adhesion 
barriers in minimally invasive surgery.
2. The problem of adhesive small bowel obstruction
The vast majority of adhesions develop after abdominal or pelvic surgery, 
although adhesions can also form after abdominal and pelvic radiation and 
peritoneal inflammation [2]. Adhesions are associated with a lifelong risk of 
ASBO. Incidence and morbidity of ASBO might be somewhat difficult to estimate 
and compare between studies based on different definitions for ASBO. Most 
accepted definition of ASBO is an episode of SBO with the presence of adhesions 
confirmed during reoperation. However, operative confirmation of adhesions is 
often not possible because many ASBO episodes are managed non-operatively. 
Therefore a second definition of ASBO is commonly applied: an episode of SBO 
interpreted as matching ASBO on radiological imaging after excluding other poten-
tial causes of bowel obstruction e.g. hernia, tumor, bezoar.
In a systematic review, the incidence of SBO by any cause after surgery is esti-
mated 9% [1]. In 42 etiological studies on SBO, adhesions accounted for 56% of all 
SBO episodes, either by operative confirmation or by excluding all other potential 
causes of SBO [1]. The incidence of postoperative ASBO confirmed by surgery is 
estimated at 2.4%. Depending on the type of initial surgical procedure, the inci-
dence varied between 0.5 and 4.2% [1]. As mentioned, this estimate is conservative 
because most episodes of ASBO are managed non-operative.
Another way to estimate the burden of ASBO is based on population stud-
ies. In the SCAR study more than one in three patients were readmitted for a 
cause possibly related to adhesions, and more than 1 in 20 patients (6%) who 
underwent open abdominal or pelvic surgery were readmitted for a directly 
adhesion-related cause [11]. The most common diagnosis for a directly adhesion-
related readmission was ASBO [11]. More recent population studies in the UK 
and USA show that ASBO remains a major contributor to the morbidity, mortal-
ity and costs related to emergency abdominal surgery. In the UK in 2016, 51% of 
all emergency laparotomies were for ASBO [20]. Similar results were found in 
the USA between 2008 and 2011, where SBO needing adhesiolysis belonged to 
the top 5 of emergency surgical procedures [21]. Given these numbers and the 
number of patients undergoing abdominal or pelvic surgery, the impact of ASBO 
on a population level is high.
ASBO causes significant morbidity and a hospital admission for SBO is associ-
ated with 2.5% mortality [1]. Initial non-operative management of ASBO includes 
gastric decompression, fluid resuscitation and nil per os, which is successful in 
70–90% [1–23]. In a sizable number of cases ASBO will result in emergency or 
delayed, after failed initial conservative management, abdominal surgery. Open 
or minimally invasive adhesiolysis to resolve the obstruction is associated with 
a incidence of 6–20% enterotomies [24, 25]. In general, complex adhesiolysis is 
associated with bleeding, sepsis, wound infections and increased mortality, even 
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in the absence of bowel injury [26]. Mean length of hospital stay for ASBO ranges 
from 4 to 13 days and generally depends the type of treatment and the treatment 
complications [1].
Both operative and conservative management of ASBO are associated with a risk 
of recurrent ASBO. Operative management includes repeated peritoneal injury with 
risk of adhesion reformation and re-ASBO. Non-operative management of ASBO 
does not dissolve abdominal adhesions and harbors the risk of a new episode of 
ASBO. In a recent study of patients presenting with a first episode of ASBO, opera-
tive management was associated with a lower risk of recurrence compared with 
non-operative management (13% vs. 21%) after a median follow-up of 3.6 years 
[19]. The study also showed an increased risk of ASBO with every previous episode 
of ASBO in accordance to findings done 25 years ago [27]. Also the time between 
episodes of ASBO decreases with an increase in number of episodes [19]. Despite 
the higher recurrence rate after conservative treatment, current guidelines still 
recommend a trial of non-operative management of ASBO in order to avoid the risk 
of complications associated with surgical intervention [28].
Effort is made to predict the severity of ASBO using peri-operative scores 
[29, 30]. However, the scores are not widely adopted for clinical use. The 
American Association for the Surgery of Trauma (AAST) developed a score 
based on clinical, imaging, operative and pathologic criteria to grade disease 
severity of ASBO [31, 32]. The AAST grade uses clinical criteria (flatus, bowel 
sounds abdominal distention), pathologic criteria (bowel perforation), imaging 
criteria on CT (intestinal distention, transition point, contrast flow) and opera-
tive criteria (intestinal distention, impeding bowel compromise, peritonitis) 
to define the grade of ASBO on a scale from 1 to 4. A higher AAST score for 
emergency ASBO is associated with an increase in length of hospital stay, pneu-
monia, and more severe complications [33]. Recently the Clinical Adhesion Score 
(CLAS) was developed, measuring the full spectrum of the long-term burden 
of adhesion formation in post-operative patients. CLAS calculates the overall 
morbidity based on four domains: ASBO, difficulties during reoperation, female 
infertility or subfertility, and chronic abdominal pain (data not yet published). 
Evaluation of current and new adhesion prevention strategies regarding long-
term clinical efficacy e.g. ASBO could benefit from using CLAS.
The economic burden of ASBO is high. Operative management is the single 
most important determinant of costs. However, based on fewer recurrences 
of ASBO after surgical treatment, surgery may save costs at the long term 
[34]. Several studies have been reported regarding the treatment costs of 
ASBO. Most have important limitations reporting part of the costs or costs based 
on reimbursement prices rather than true healthcare costs [35–37]. We mod-
eled in a recent study, costs for ASBO in the Netherlands using a micro-costing 
method including costs of length of stay, ICU days, operative time, medication, 
parenteral feeding, imaging studies and laboratory studies [38]. This model-
ing revealed total healthcare costs of patients operated for ASBO of €16305 
(SD €2513) with a mean hospital stay of 16.0 ± 11 days. For non-operatively 
treated patients costs would be €2277 (SD €265) with a mean hospital stay 
of 4.0 ± 2.0 days. The majority of the costs were due to ward stay, operative 
time, ICU stay and (parental) feeding. All surgical procedures for ASBO in this 
study consisted of open adhesiolysis. Costs estimated in this study were higher 
compared to previous estimates of treatment costs for ASBO with comparable 
lengths of stay and, as a result of its design better reflecting reality [35–37]. In 
the study we adhered to international guidelines for the diagnosis and treat-
ment of ASBO increasing generalizability of outcomes for developed countries. 
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Nevertheless costs may vary among countries due to differences in admission 
and discharge policies, and prices of diagnostics, materials, medication and 
feeding.
3. Impact of minimally invasive surgery on morbidity of ASBO
It has been suggested from a few studies that the decreased adhesion formation 
after minimally invasive surgery associates with a lower incidence of ASBO. This 
decrease seems limited compared to open surgery as concluded from one systematic 
review and one trial reported by our group [1–17]. Differences in definitions of 
ASBO used, types of procedures, outcome parameters and length of follow-up in 
the studies, preclude a firm conclusion on the beneficial effect of minimally inva-
sive surgery on development of ASBO.
To estimate the impact of minimally invasive surgery at a population level on 
adhesion-related complications, ASBO in particular, our group recently reported 
the results of the SCAR update study [39]. Over 72,000 patients, who were oper-
ated between June 2009 and June 2011, were followed for a minimum of 5 years. 
Readmissions were classified, according to the initial SCAR study (1999), as 
directly-related to adhesions e.g. adhesive small bowel obstruction, possibly 
related to adhesions, e.g. any small bowel obstruction and reoperations potentially 
complicated by adhesions e.g. right hemicolectomy years after an appendectomy. 
Approximately 30% of all index procedures were minimally invasive. Patients who 
underwent minimally invasive surgery were readmitted less frequently for directly 
related causes compared with patients after open surgery (1.7% vs. 4.3%). Possibly 
related readmissions and reoperations potentially complicated by adhesions were 
also less frequent (16.0% vs. 18.2% and 8.6% vs. 15.0%). Multivariate analysis 
revealed a 32% reduction in directly adhesion-related readmissions associated 
with minimally invasive surgery. Readmission rates were similar when comparing 
patients with open surgery in the SCAR and those in the SCAR update study. The 
overall small differences found in readmission rates could be explained by the 
difference in follow-up, 10 years in the SCAR study and 5 years in the SCAR update 
study. Despite the finding of a small reduction in readmission rates after initial 
minimally invasive surgery, the overall burden of adhesion-related readmissions on 
a population level remains high.
To further elaborate differences in adhesion-related readmissions between mini-
mally invasive and open surgery, we analyzed patients with colorectal procedures 
(data not yet published). This type of surgery is known for its adhesion formation 
propensity and associated morbidity. Over 15,000 patients underwent colorectal 
surgery of whom almost one-third with a minimally invasive approach. For open 
colorectal surgery readmission rates were comparable between the SCAR study and 
the SCAR update study. Minimally invasive colonic and/or rectal surgery reduced 
the total number of directly adhesion-related readmissions. However in patients 
who underwent a (sub)total colectomy readmission rates were over 15% irrespec-
tive of an open or minimally invasive approach. Minimally invasive surgery did not 
reduce adhesion-related complications in rectal procedures. We concluded that an 
extended colectomy and rectal resection do not benefit from minimally invasive 
surgery regarding adhesion-related complications. We hypothesized that the large 
extent of the dissection and injury to the visceral and lateral parietal peritoneum 
needed in both surgical techniques abolishes the preventive effect of the minimally 
invasive technique on adhesion formation to the ventral peritoneum, where the 
injury is relatively limited for both approaches.
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The SCAR update study has demonstrated that minimally invasive surgery 
is associated with less adhesion-related readmissions. Hence, the overall burden 
of adhesion-related readmissions on a population level remains high. Adhesion 
formation therefore continues to be a challenge in abdominal surgery, also in the 
minimally invasive era. Minimally invasive procedures were only performed in 
approximately one-third of procedures in 2009–2011, whereas currently in the 
Netherlands about 75% of colonic resections are performed minimally invasive 
(by laparoscopy or robot) [40]. On a population base a further decline in adhesion-
related complications can be expected with an increase of minimally invasive 
abdominal operations. However, we like to warn against unbridled optimism 
regarding the overall impact of minimally invasive surgery on the burden of adhe-
sions because open surgery is still being preferred when a complicated condition 
is expected in the abdominal cavity e.g. after multiple previous procedures, with 
large inflammatory mass or locally advanced cancer [41]. Many of these conditions 
are complex specifically due to presence of adhesions at baseline surgery and the 
need to perform adhesiolysis before entering the operative area. It is known that the 
propensity to reform adhesions after adhesiolysis is higher than de novo adhesion 
formation.
4. Management of adhesive small bowel obstruction
Adequate management of ASBO depends on an initially correct diagnosis. 
Although ASBO is a common diagnosis with clear signs and symptoms, misdiag-
nosis and delayed diagnosis are a substantial clinical problem. Up to 50% of older 
patients are initially not adequately diagnosed [42]. Failure to diagnose represents 
70% of malpractice claims in ASBO [43, 44]. In this regard it is important to note 
that patients with ASBO can initially present themselves to a variety of physicians, 
including general practitioners, surgeons, internal medicine physicians, geriatri-
cians and gastroenterologists. To improve diagnosis of ASBO, multiple specialists 
need to be involved in practice guidelines and protocols.
Based on expert opinion the diagnosing of ASBO includes a medical history with 
an assessment of potential causes of SBO, e.g. previous abdominal surgery, inflam-
matory bowel disease, important symptoms such as vomiting, absence of stools or 
flatus, intermittent colicky abdominal pain and abdominal distention. Common 
pitfalls in diagnosing ASBO are the less prominent pain present in the elderly [42], 
reporting of watery diarrhea by patients with an incomplete obstruction and nor-
mal stool passage in the first days after onset due to stool still present in the colon.
The recent update of the international guidelines for diagnosis and management 
of ASBO gives the current best available evidence for management of ASBO once 
the diagnosis of bowel obstruction has been established [28]. The first priority in 
management is to establish the cause of obstruction and to determine if urgent 
surgical treatment is required. ASBO is the single most common cause for SBO, the 
differential diagnosis includes strangulated abdominal wall or groin hernia, tumor, 
paralysis, constipation or bezoars. Laboratory tests should include blood count, 
CRP, electrolytes, creatinine and lactate. Imaging studies can include water-soluble 
contrast studies or computer tomography (CT) scans. CT scan is the preferred 
imaging technique for the diagnosis of ASBO, it can accurately rule out other causes 
of obstruction and identify patients who might require emergency surgery [28]. 
Water-soluble contrast enhances the diagnostic accuracy of CT scans. Signs that 
might suspect ASBO on imaging studies are an abrupt change in bowel diameter 
and the exclusion of other causes of SBO. The value of plain X-rays is limited [28].
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Urgent surgery is required in case of signs of ischemia, perforation or strangula-
tion of the bowel, generalized peritonitis and/or hemodynamic instability. No single 
test is highly sensitive for ischemia and strangulation. Sensitivity of physical exami-
nation for the detection of strangulation is only 48% in experienced hands [45]. 
Laboratory tests indicating peritonitis or ischemia are a CRP above 75 and a white 
blood cell count above 10.000/mm3 [45–47]. Again, a CT scan is most accurate in 
assessing strangulation and perforation and the need for emergency surgery [28]. 
CT abnormalities indicating strangulation or perforation are free intraperitoneal 
air or fluid, closed loop obstruction, mesenteric edema or engorgement, mesenteric 
swirling, pneumatosis intestinalis, decreased or lack of bowel enhancement or 
thickened bowel wall [48–50].
If bowel obstruction is caused by adhesions, and signs of peritonitis, ischemia, 
and strangulation are absent, initial conservative treatment is reportedly safe. 
Conservative treatment is successful in 70–90% of all episodes of ASBO [1–23]. 
Conservative treatment of ASBO consists of nil per os and decompression of the 
gastro-intestinal tract using a naso-gastric tube. Further management includes 
fluid resuscitation, correction of electrolyte disturbances, nutritional support and 
prevention of aspiration. Optimal duration of a conservative trial is debated; pro-
longed management for more than 72 h has been associated with adverse outcomes 
and increased mortality [20, 51–54]. Water-soluble contrast studies seem useful in 
the follow-up of conservative management of ASBO. If contrast has not reached to 
colon 24–48 h following administration, continuation of conservative management 
is likely to fail and surgical management should be considered [28].
An algorithm for the diagnosis and treatment of ASBO is presented in 
Figure 2 [28].
4.1 Role of minimally invasive surgery in the management of ASBO
Operative treatment of ASBO historically comprises an explorative laparotomy 
with adhesiolysis. The increased use of minimally invasive surgery has raised 
the question whether minimally invasive surgery is feasible and effective for the 
treatment of ASBO. Benefits of minimally invasive adhesiolysis are reduction of 
peritoneal injury possibly resulting in less adhesion reformation, a quick recovery 
and minimal post-operative pain. Twenty-five years ago the first cases of minimally 
invasive surgery for treatment of ASBO have been described [55]. Thereafter a few 
series were reported but adequate comparative trials are scarce [56–60]. Minimally 
invasive surgery for ASBO is challenging because there is little laparoscopic working 
space due to the distended bowel. Also visibility can be hampered by multiple adhe-
sions. There are concerns that minimally invasive surgery increases the risk of iat-
rogenic bowel perforations [57]. Suitability of minimally invasive surgery for ASBO 
further depends on patient characteristics. In case of hemodynamic instability open 
surgery is required because patients cannot tolerate the pneumoperitoneum.
One randomized trial comparing minimally invasive and open surgery for ASBO 
has been performed [56]. Only patients with a high suspicion of a single adhesive 
band causing the obstruction were included. Patients with confirmed or suspected 
peritoneal carcinosis, known multiple adhesions, previous open surgery for endo-
metriosis, aorta, iliac vessels or Crohn’s disease, previous generalized peritonitis, 
abdominal malignancy, previous abdominal radiotherapy or recent operations 
within 30 days were all excluded. Patients started with conservative management 
of ASBO. If the obstruction did not resolve patients were randomized between open 
and laparoscopic adhesiolysis. The trial was open label, therefore patients and care 
providers were not blinded. During 5 years 566 patients were included in the study, 
104 patients underwent surgery, 51 were randomly assigned to the open surgery 
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group, and 53 to the laparoscopic surgery group. Patients in the laparoscopic group 
had a shorter length of stay (4.2 days) compared with the open group (5.5 days). 
Mortality and postoperative complications did not differ between the groups.
The few matched cohort studies comparing minimally invasive and open 
surgery for ASBO reported comparable results to those of the trial mentioned above 
Figure 2. 
Algorithm for the diagnosis and treatment of ASBO.
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[59, 60]. There seems a trend towards a faster recovery in selected patients. Studies 
showed no major differences in complications or mortality. A few studies specifi-
cally addressed the potential drawbacks of the minimally invasive approach and 
suggested an increased risk of bowel injury [59]. Notably, the non-matched cohorts 
frequently claim large beneficial effects of the laparoscopic approach [40–58]. 
However, these studies have a high risk of various types of selection bias, mainly 
excluding patients who are more sick or are suspected of multiple adhesions.
It seems that minimally invasive adhesiolysis holds promise for patients with 
signs of a single adhesive band and an uncomplicated disease course. Further studies 
are needed to identify patients who can benefit from minimally invasive adhesiolysis 
and patients who can be harmed by minimally invasive treatment for ASBO.
5. Future perspectives
5.1 Awareness of adhesions formation by minimally invasive surgery
Morbidity of adhesion formation in minimally invasive surgery is often under-
estimated. Less than 25% of surgeons and 5–83% of gynecologists routinely inform 
their patients about adhesions and the life term risk of adhesion-related complica-
tions [14–62]. However, recent evidence shows that adhesion-related morbidity 
remains high in the minimally invasive era [39]. Not informing patients about the 
risk of adhesions might therefore be considered negligent. Increased awareness of 
adhesions might create an urge for the development and refinement of adhesion 
prevention strategies.
Awareness of adhesions may improve by growing awareness for intra-operative 
complications in general. Impact of adhesions on the operative course of reop-
erations for ASBO or other indications is often underreported. In a prospective 
comparison of operative notes and observation by an independent researcher, one 
in seven iatrogenic bowel injuries was not reported in operative notes, and almost 
one in three minor injuries [63]. In recent years, there is increasing scientific 
interest in the consequences of intra-operative events. IAEs are associated with 
40% more hospital admissions, a twofold higher readmission rate, and with worse 
post-operative outcome [64–70]. Recently the Classification of Intraoperative 
Complications (CLASSIC) has been developed as a new tool for systematic clas-
sification for intra-operative complications (iAEs) [71]. CLASSIC defines iAEs as 
any deviation from the ideal intraoperative course, including technical failures, 
surgical and anesthesiological difficulties. The score has been update to five grades 
of severity (https://clinicaltrials.gov/ct2/show/NCT03009929). Lysis of adhesions 
at reoperations is associated with post-operative increase of sepsis, intra-abdominal 
complications, wound infections, longer hospital stay, and higher hospital costs 
[26–72]. As such, adhesiolysis qualifies as an iAE if adhesiolysis is not the intended 
surgical procedure. We currently investigate the contribution of adhesiolysis and 
associated intra-operative complications e.g. bleeding, inadvertent enterotomy to 
the CLASSIC.
Recent published guidelines may also increase awareness of adhesions and 
treatment of ASBO [28]. An old saying on ASBO is ‘you must not let the sun rise on 
ASBO’, all patients presenting with ASBO were operated if conservative manage-
ment failed to resolve the bowel obstruction within 24 h. Recent insights report that 
a conservative trial can safely be prolonged to 72 h [51, 52]. The current guideline 
states that conservative treatment should be instigated in all patients without signs 
of ischemia, perforation or strangulation of the bowel, generalized peritonitis 
and/or hemodynamic instability [28]. Contradictory, some studies report lower 
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recurrence rates of ASBO after surgical management of ASBO [19–27]. A further 
disadvantage of prolonged conservative management is the further clinical deterio-
ration of highly comorbid patients who receive starvation treatment for a few days 
[73]. Minimally invasive surgery could change the paradigm again towards earlier 
surgical intervention because of faster recovery, reduced length of hospital stay and 
the mentioned lower recurrence rates of ASBO.
5.2 Adhesion reduction strategies
Considering the high impact of adhesion-related complications on a population 
level that is not substantially decreased by minimally invasive surgery, there is a 
pressing need to develop new adhesion reduction strategies.
Until now the most promising approach for reduction of adhesion formation is 
routinely applying an adhesion barrier. Adhesion barriers are bioresorbable liquids, 
gels or films that keep injured peritoneal wound surfaces separated. During separa-
tion the peritoneal wound can heal with restoration of peritoneal tissue morphol-
ogy and function without ‘scarring’ (adhesions). A large systematic review and 
meta-analysis in 2014 of 28 trials (n = 5191) showed benefits of several adhesion 
barriers in predominantly open abdominal surgery [16]. However, adhesion barriers 
are seldomly applied in abdominal or pelvic surgery [14]. Only 1 in 7 surgeons ever 
uses adhesion barriers [14]. Reluctance of surgeons to use adhesions barriers seems 
caused by doubts about cost-effectiveness and the need and possibility of adhesion 
prevention in minimally invasive surgery.
Cost-effectiveness of adhesion prevention in minimally invasive surgery is an 
important perquisite for implementation in every day practice. We performed a 
modeling study on cost-effectiveness of adhesion barriers in minimally invasive 
procedures with a high risk of adhesion formation [74]. Two strategies were com-
pared: current clinical practice (colorectal surgery without the use of an adhesion 
barrier) and colorectal surgery with the use of an adhesion barrier (hyaluronate 
carboxymethylcellulose). Whilst hyaluronate carboxymethylcellulose as such is 
not applicable in minimally invasive surgery and a gel form has not properly been 
studied in minimally invasive surgery, probabilities were extrapolated from data of 
open colorectal surgery. Probability estimates were derived from literature. Costs of 
treatment of ASBO were derived from our previous report [38]. Cost of hyaluronate 
carboxymethylcellulose was estimated on $630, based on the mean number of films 
used in studies on hyaluronate carboxymethylcellulose [12–75]. We concluded that 
using an adhesion barrier was more effective than not using a barrier in minimally 
invasive surgery, but it was more expensive. However, mean expected direct 
healthcare costs in the 4 years following index surgery increased with only $163 per 
patient. Cost estimates in this modeling study only included direct health care costs. 
Societal costs (e.g. absence from work) were not modeled in this study. Therefore an 
increase of $163 in direct health care may be neglectable considering potential gain 
in societal costs. Further research is needed on long term savings regarding socio-
economic costs with adhesion barriers also including the new SCAR update data of 
minimally invasive surgery.
An important limitation of most barriers is the inability to properly use these 
in minimally invasive surgery. Most barriers were developed more than two to 
three decades ago and were films intended for use in open surgery. This limitation 
and the disregard needing barriers in minimally invasive surgery have impeded 
implementation and continued research and development of barriers suitable 
for minimally invasive surgery (and open surgery). Recently some new barriers 
have been developed suitable for minimally invasive surgery. Studies on these new 
barriers are performed mostly in gynecologic populations, and show effectiveness 
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reducing adhesions [76, 77]. The important next step in adhesion prevention is the 
development of a new generation of barriers suitable for minimally invasive use 
in general surgery [78, 79]. Using increased knowledge of the pathophysiology of 
adhesions, new barriers consist of bioactive and targeted technology e.g. modula-
tion of inflammation [2]. Pilpel and colleagues developed a liquid solution modulat-
ing the fibrin matrix which is generated by the hemostatic system after peritoneal 
injury [80]. This novel therapy is currently tested in animal models. Roberston and 
colleagues are testing a drug (L-Alanyl-L-Glutamine) to regulate the formation 
of adhesions due to hypoxia and oxidative stress caused by surgical injury of the 
vascular supply to the tissue caused by surgical intervention [81]. The first results 
of this drug in a double-blinded placebo controlled study show that L-Alanyl-
L-Glutamine is safe to use and is effective at reducing adhesion formation after 
laparoscopic myomectomies [82]. Definitive results from this study are expected in 
due time. When proven safe, effective and affordable in patients, these new bioac-
tive and targeted technology agents should be administered during index minimally 
invasive surgery to break the sequence of intra- and postoperative adhesion-(re)
formation related complications.
6. Conclusions
Adhesion-related morbidity remains a clinically relevant problem in the mini-
mally invasive era. Minimally invasive surgery is associated with only a modest 
reduction in adhesion-related readmissions and incidence of ASBO. The growing 
body of scientific evidence provides the clinician with a firm guideline for the diag-
nosis and treatment of ASBO. Minimally invasive surgery in the management of 
ASBO appears to be safe and effective alternative to open adhesiolysis, however in 
a very selected patient group. To allow as many patients as possible to benefit from 
a minimally invasive approach future research should focus on the selection crite-
ria for minimally invasive surgery in ASBO. Adhesion-related morbidity is often 
underestimated and complications of adhesiolysis underreported. Raising aware-
ness of adhesions therefore remains important. Using newly proposed scores for 
intraoperative complications, may increase awareness for the intra-operative events 
caused by adhesions. Adhesion barriers can safely reduce adhesion formation, are 
cost-effective in open colorectal surgery and effective with slightly higher costs in 
minimally invasive surgery. Future research should focus on new bioactive barriers 
that are easily applicable in minimally invasive abdominal surgery and safe to use. 
Preventing adhesions during first minimally invasive surgery is key to break the 
sequence of intra- and postoperative adhesion (re)formation related complications.
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